Operating loss (EBIT) amounted to MSEK -5.6 (-4.5)
Net loss amounted to MSEK -5.5 (-4.5)
Net cash flow amounted to MSEK -4.6 (-7.4)
EPS before and after dilution amounted to SEK -0.06 (-0.17)
JANUARY- SEPTEMBER 2023
Net sales amounted to MSEK 0.0 (0.0)
Operating loss (EBIT) amounted to MSEK -17.8 (-20.5)
Net loss amounted to MSEK -18.3 (-20.5)
Net cash flow amounted to MSEK 7.7 (-9.1)
EPS before and after dilution amounted to SEK -0.32 (-0.87)
Significant events During the reporting period
In August, Emplicure hired Johan Magné as Sales Director with a long background in Swedish Match to drive the company's sales of smååTM.
In September, the company received a research grant of MSEK 1.0 from Vinnova, Sweden's Innovation Authority, within the framework of the competence center SweDeliver.
Also in September, the company announced that the company, through its subsidiary Amplicon, initiates a collaboration on a clinical study with CTC Clinical Trial Consultants AB, a recognized contract research organization (CRO).
After the reporting period
In October the company was informed that a buyout consortium had agreed to acquire over 90 per cent of the shares in Emplicure and intends to initiate squeeze-out proceedings.
In November Emplicure announced the hiring of a marketing manager, Sophia Bailey
In November the buyout consortium initiated squeeze-out proceedings and Emplicure applied for delisting. Nasdaq approved the delisting with the 27 November as the last trading day
About Us Emplicure uses patented bioceramic technology to develop innovative and effective products to help consumers and patients live better lives. Our consumer division makes tiny, long-lasting and flavorful nicotine pouches that can be an alternative to smoking. Our pharmaceutical division develops safer and tamper-resistant treatments for pain. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com
This information is information that Emplicure is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-11-17 07:58 CET.